Psoriatic Arthritis Remission Compared With Very Low Disease Activity, DAPSA Criteria - Rheumatology Advisor
Descriptive statistics for DAPSA on weeks 12 and 24 | Download Table
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text
UvA-DARE (Digital Academic Repository)
What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis?
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
Digital Tools for Assessing Disease Severity in Dermatology. - Abstract - Europe PMC
Dapsa Eng | PDF
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
RheumaHelper
UvA-DARE (Digital Academic Repository)
Frontiers | Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature
The Patient's Perspective on Psoriatic Arthritis: What more can Rheumatologists do to Optimise Disease Management? - European Medical Journal
POS1069 VALIDATION OF THE DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS ( DAPSA) WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (Q-DAPSA) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): A PROSPECTIVE, NATIONAL, MULTICENTER STUDY | Annals
Frontiers | Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
Home
Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab - Helliwell - 2014 - Arthritis Care & Research - Wiley Online Library
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World